NO20045038L - Kombinasjon av en beta-2 adrenoseptoragonist og et aminosukker og deres anvendelse ved behandling av immunomodulerende sykdommer - Google Patents

Kombinasjon av en beta-2 adrenoseptoragonist og et aminosukker og deres anvendelse ved behandling av immunomodulerende sykdommer

Info

Publication number: NO20045038L
Authority: NO; Norway
Prior art keywords: beta; treatment; amino sugar; combination; adrenoceptor agonist
Prior art date: 2002-04-19

Application number

NO20045038A

Other languages

English (en)

Norwegian (no)

Inventor

Morten Sloth Weidner

Original Assignee

Astion Dev As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-19

Filing date

2004-11-19

Publication date

2004-11-19

2004-11-19 Application filed by Astion Dev As filed Critical Astion Dev As

2004-11-19 Publication of NO20045038L publication Critical patent/NO20045038L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Neurology (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Transplantation (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)

NO20045038A 2002-04-19 2004-11-19 Kombinasjon av en beta-2 adrenoseptoragonist og et aminosukker og deres anvendelse ved behandling av immunomodulerende sykdommer NO20045038L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US37361502P	2002-04-19	2002-04-19
DKPA200200586		2002-04-19
PCT/DK2003/000263 WO2003097073A1 (en)	2002-04-19	2003-04-22	Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders

Publications (1)

Publication Number	Publication Date
NO20045038L true NO20045038L (no)	2004-11-19

Family

ID=49447268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20045038A NO20045038L (no)	2002-04-19	2004-11-19	Kombinasjon av en beta-2 adrenoseptoragonist og et aminosukker og deres anvendelse ved behandling av immunomodulerende sykdommer

Country Status (17)

Country	Link
US (1)	US20050130935A1 (de)
EP (2)	EP1642574A3 (de)
JP (1)	JP2005529151A (de)
KR (1)	KR20050007460A (de)
CN (1)	CN1646143A (de)
AT (1)	ATE311889T1 (de)
AU (1)	AU2003260279B2 (de)
CA (1)	CA2482746A1 (de)
DE (1)	DE60308915T2 (de)
DK (1)	DK1496917T3 (de)
EA (1)	EA007906B1 (de)
ES (1)	ES2254960T3 (de)
NO (1)	NO20045038L (de)
NZ (1)	NZ536447A (de)
PL (1)	PL373190A1 (de)
SI (1)	SI1496917T1 (de)
WO (1)	WO2003097073A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7666843B2 (en)	2002-09-27	2010-02-23	Children's Medical Center Corporation	Methods and compositions for treatment of neurological disorder
WO2005089741A2 (en) *	2004-03-17	2005-09-29	Sosei R&D Ltd.	The treatment of inflammatory disorders and pain using beta-aminoalcohols
SI1719507T1 (sl)	2005-04-13	2010-11-30	Astion Dev As	Beta adrenoceptor agonisti za zdravljenje bolezni veznega tkiva kože
WO2007028247A1 (en) *	2005-09-09	2007-03-15	University Of Manitoba	Fast-disintegrating epinephrine tablets for buccal or sublingual administration
WO2011109340A1 (en)	2010-03-01	2011-09-09	Nova Southeastern University	Epinephrine nanop articles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20160045457A1 (en)	2005-09-09	2016-02-18	Ousama Rachid	Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
WO2014153559A1 (en)	2013-03-22	2014-09-25	Nova Southeastern University	Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
US9877921B2 (en)	2005-09-09	2018-01-30	Nova Southeastern University	Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
GB0604826D0 (en) *	2006-03-09	2006-04-19	Arakis Ltd	The treatment of inflammatory disorders and pain
TW200817049A (en) *	2006-06-05	2008-04-16	Verus Pharmaceuticals Inc	Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20070293580A1 (en) *	2006-06-05	2007-12-20	Malcolm Hill	Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
GB0625270D0 (en) *	2006-12-19	2007-01-31	Univ Leicester	Angiogenesis
WO2008150477A2 (en) *	2007-05-31	2008-12-11	Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health	N-acetyl mannosamine as a therapeutic agent
GB0805535D0 (en)	2008-03-27	2008-04-30	Univ Leicester	Scar prevention
WO2010144865A2 (en)	2009-06-12	2010-12-16	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
US8716349B2 (en)	2010-03-30	2014-05-06	Algynomics Inc.	Compositions and methods for the treatment of somatosensory disorders
US8716350B2 (en)	2010-03-30	2014-05-06	Algynomics Inc.	Compositions and methods for the treatment of somatosensory disorders
EP2753321B1 (de)	2011-10-21	2021-12-15	Nova Southeastern University	Epinephrinnanopartikel, herstellungsverfahren dafür und verfahren zur verwendung davon zur behandlung von leiden als reaktion auf epinephrin
EP2861224A4 (de)	2012-06-15	2015-11-18	Univ Nova Southeastern	Epinephrinnanopartikel, verfahren zur herstellung davon und verfahren zur verwendung davon zur behandlung von auf epinephrin ansprechenden leiden
GB2513297A (en)	2013-03-08	2014-10-29	Univ Leicester	Methods
CN105601685B (zh) *	2016-01-08	2017-12-26	鲁东大学	含喹唑啉环壳寡糖衍生物及制备方法和生物活性
WO2018000098A1 (en) *	2016-06-30	2018-01-04	Cipher Pharmaceuticals Inc.	Treatment of inflammatory myopathies
US12357591B2 (en)	2018-10-19	2025-07-15	Nova Southeastern University	Sublingual epinephrine compositions including pH-modifying excipients and penetration enhancers and methods for use thereof
IL302158A (en) *	2020-10-20	2023-06-01	Univ California	Compositions and methods for treating ischemic conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4647453A (en) *	1984-10-18	1987-03-03	Peritain, Ltd.	Treatment for tissue degenerative inflammatory disease
JP3390477B2 (ja) *	1993-01-25	2003-03-24	生化学工業株式会社	薬剤組成物及びその製造法
WO1995019336A1 (de) *	1994-01-12	1995-07-20	Iovis Biomedical And Pharmaceutical Consultants	Phenylethanolaminether und ihre verwendung als beta-adrenorezeptor-agonisten
US6255295B1 (en) *	1996-12-23	2001-07-03	Nutramax Laboratories, Inc.	Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6046179A (en) *	1998-04-17	2000-04-04	Murch; Simon	Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US20020136782A1 (en) *	2001-01-18	2002-09-26	Fleischner Albert M.	Composition patent for solid-dosage form of weight loss product
US6420350B1 (en) *	2001-01-18	2002-07-16	Goen Group, Inc.	Weight loss product

2003
- 2003-04-22 SI SI200330173T patent/SI1496917T1/sl unknown
- 2003-04-22 PL PL03373190A patent/PL373190A1/xx not_active Application Discontinuation
- 2003-04-22 AT AT03752710T patent/ATE311889T1/de not_active IP Right Cessation
- 2003-04-22 US US10/512,029 patent/US20050130935A1/en not_active Abandoned
- 2003-04-22 WO PCT/DK2003/000263 patent/WO2003097073A1/en not_active Ceased
- 2003-04-22 EP EP05013726A patent/EP1642574A3/de not_active Withdrawn
- 2003-04-22 KR KR10-2004-7016710A patent/KR20050007460A/ko not_active Withdrawn
- 2003-04-22 NZ NZ536447A patent/NZ536447A/en unknown
- 2003-04-22 CN CNA038087146A patent/CN1646143A/zh active Pending
- 2003-04-22 DE DE60308915T patent/DE60308915T2/de not_active Expired - Fee Related
- 2003-04-22 ES ES03752710T patent/ES2254960T3/es not_active Expired - Lifetime
- 2003-04-22 AU AU2003260279A patent/AU2003260279B2/en not_active Expired - Fee Related
- 2003-04-22 EP EP03752710A patent/EP1496917B1/de not_active Expired - Lifetime
- 2003-04-22 CA CA002482746A patent/CA2482746A1/en not_active Abandoned
- 2003-04-22 JP JP2004505071A patent/JP2005529151A/ja active Pending
- 2003-04-22 DK DK03752710T patent/DK1496917T3/da active
- 2003-04-22 EA EA200401404A patent/EA007906B1/ru not_active IP Right Cessation
2004
- 2004-11-19 NO NO20045038A patent/NO20045038L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DK1496917T3 (da)	2006-04-10
JP2005529151A (ja)	2005-09-29
DE60308915T2 (de)	2006-12-21
CA2482746A1 (en)	2003-11-27
ES2254960T3 (es)	2006-06-16
HK1073436A1 (en)	2005-10-07
KR20050007460A (ko)	2005-01-18
CN1646143A (zh)	2005-07-27
DE60308915D1 (de)	2006-11-16
EP1642574A3 (de)	2008-11-12
NZ536447A (en)	2006-05-26
EP1496917A1 (de)	2005-01-19
ATE311889T1 (de)	2005-12-15
PL373190A1 (en)	2005-08-22
EP1642574A2 (de)	2006-04-05
AU2003260279A1 (en)	2003-12-02
EA200401404A1 (ru)	2005-04-28
SI1496917T1 (sl)	2006-06-30
WO2003097073A1 (en)	2003-11-27
EA007906B1 (ru)	2007-02-27
EP1496917B1 (de)	2005-12-07
AU2003260279B2 (en)	2008-01-24
US20050130935A1 (en)	2005-06-16

Legal Events

Date	Code	Title	Description
2008-11-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1496917T3 (da)	2006-04-10	Kombination af en beta-2-adrenoceptoragonist og en aminosukker og anvendelse deraf til behandling af immunmodulerende lidelser
WO2007014334A3 (en)	2007-04-19	Method of treatment or management of stress
WO2005023185A3 (en)	2005-05-19	Pharmaceutical compositions and method of using levodopa and carbidopa
WO2007143231A3 (en)	2009-08-27	Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
RU2008103480A (ru)	2009-08-10	Средство, содержащее l-карнитин или производные l-карнитина и, по меньшей мере, одно определенное другое вещество
NO20045521L (no)	2004-12-17	Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
NO20065260L (no)	2006-11-21	Tri(cyklo)substituerte amidforbindelser
WO2004089353A8 (en)	2005-09-01	Methods for treatment of parkinson's disease
TW200637488A (en)	2006-11-01	Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging
NO331211B1 (no)	2011-10-31	¿ Beta-2 adrenoreseptor agonister for behandling av bindevevsykdommer i huden¿
WO2005051297A3 (en)	2006-07-20	Combination drug therapy to treat obesity
WO2008070859A3 (en)	2008-07-31	Treatment of skin conditions by dickkopf1 (dkk1)
DE60124715D1 (de)	2007-01-04	Er produktion von beta-endorphin
EP2772260A3 (de)	2014-10-15	Therapeutische Zusammensetzungen mit Hyaluron und therapeutischen Antikörpern sowie Behandlungsverfahren
AU2003304410A1 (en)	2005-03-07	Agents and methods for treatment of disease by oligosaccharide targeting agents
WO2003088748A8 (en)	2004-01-29	Use of heme oxygenase-1 and products of heme degradation
WO2004091540A3 (en)	2006-02-02	Methods of treating pain and compositions for use therefor
BRPI0508137A (pt)	2007-07-24	composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
WO2004103283A3 (en)	2007-08-16	Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
NO20050718L (no)	2005-04-01	Topikal behandling av hudsykdommer
WO2004014367A3 (en)	2004-03-25	Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease
NO20062336L (no)	2006-07-11	Kombinasjoner av kaliumkanalapnere og natriumkanalinhibitorer eller aktive substanser som pavirker natriumkanaler for behandling av smertetilstander
BR0310061A (pt)	2005-03-01	Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
PT1572178E (pt)	2006-09-29	Tratamento de mastalgia com 4-hidroxi-tamoxifeno
WO2003092645A3 (fr)	2004-04-01	Composition cosmetique comprenant des mono- ou poly-saccharides